Pharmaceutical manufacturer Astellas recently added a second medication to its 340B contract pharmacy restrictions.

Astellas Adds Second Drug to 340B Contract Pharmacy Restrictions

Japanese drugmaker Astellas will soon extend its limits on 340B pricing to hospitals for its medication to treat overreactive bladder, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at